185 , 186 Functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs
To view a copy of this licence, visit About this article Cite this article Kunwar, A., Nayak, M
We will ensure allocation concealment throughout the study as none of the investigators will have access to this list until completion of data collection
Antioxidants in the fight against atherosclerosis: is this a dead end
(PubMed) Regulatory reports: the FDA (USA) highlighted multiple adverse events linked to compounded glutathione injections from mild to severe and life-threatening
Published in vitro research characterises its molecular interactions with VEGFR2 (vascular endothelial growth factor receptor 2), demonstrating measurable binding affinity profiles under controlled laboratory conditions